查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1947535

医疗保健资料货币化市场：依资料类型、货币化模式、应用程式和最终用户划分 - 全球预测至 2036 年

Healthcare Data Monetization Market by Data Type, by Monetization Model, by Application, and by End User - Global Forecast to 2036
出版日期: | 出版商: Meticulous Research | 英文 287 Pages | 商品交期: 5-7个工作天内

价格
简介目录

全球医疗保健数据货币化市场预计将从 2026 年的 5.697 亿美元增长到 2036 年的约 287 亿美元，预测期内（2026-2036 年）复合年增长率 (CAGR) 为 17.6%。本报告对全球五大主要地区的医疗保健数据货币化市场进行了详细分析，重点关注当前市场趋势、市场规模、近期发展以及至 2036 年的预测。

基于广泛的一手和二手研究以及对市场现状的深入分析，本报告分析了关键行业驱动因素、限制因素、机会和挑战的影响。推动医疗保健数据货币化市场成长的关键因素包括全球对数据驱动型医疗保健服务的日益重视以及人工智慧的快速应用。 此外，隐私增强技术的整合、对高品质医疗数据集日益增长的需求以及联邦数据网路的扩展，预计将为医疗保健数据货币化市场中的公司创造巨大的成长机会。

市场区隔

目录

第一章：引言

第二章：摘要整理

第三章：市场概览

  • 市场动态
    • 驱动因素
    • 限制因素
    • 机遇
    • 挑战
  • 人工智慧 (AI) 和云端技术对医疗保健数据货币化的影响
  • 监管环境与资料隐私框架
  • 波特五力模型分析

第四章 全球医疗保健资料货币化市场（依资料类型划分）

  • 临床数据
    • 电子健康记录 (EHR) 数据
    • 医学影像数据
    • 实验室和诊断数据
  • 计费和财务数据
    • 保险索赔数据
    • 计费和报销数据
  • 药物及研发数据
    • 临床试验数据
    • 药物利用与治疗结果数据
  • 患者产生数据
    • 穿戴式装置和远端监测数据
    • 消费者健康应用数据
  • 营运与管理数据
    • 员工与工作安排数据
    • 供应链与采购数据

第五章：全球医疗保健资料货币化市场（以货币化模式划分）

  • 内部货币化
    • 营运效率和成本降低
    • 改善临床绩效
  • 外在货币化
    • 资料许可和资料即服务 (DaaS)
    • 研究与分析合作
    • 真实世界数据市场

第六章：全球医疗保健数据货币化市场（依应用划分）

  • 药物发现与开发
  • 临床试验管理
  • 人群健康管理
  • 收入周期管理
  • 精准医疗
  • 医疗保健营运优化

第七章：全球医疗保健数据依最终用户划分的货币化市场

  • 製药和生技公司
    • 大药厂
    • 专业製药和生技公司
  • 医疗保健提供者
    • 医院系统与综合护理网络
    • 门诊和专科护理提供者
  • 支付方
    • 私人健康保险公司
    • 政府和公共支付方
  • 医疗器材製造商
    • 诊断设备製造商
    • 数位健康与穿戴式装置公司
  • 医疗资讯科技公司
    • 电子健康记录 (EHR) 和健康资讯系统供应商
    • 健康分析平台提供者
  • 政府和研究机构机构
    • 学术医疗中心
    • 公共卫生与国家研究机构

第八章 全球医疗保健资料货币化市场（依地区划分）

  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 荷兰
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 东南亚
    • 澳大利亚
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区美洲
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 南非
    • 中东和非洲其他地区

第九章 竞争格局

  • 关键成长策略
  • 竞争标竿分析
  • 竞争概览
    • 行业领导者
    • 市场差异化因素
    • 先锋企业
    • 新兴企业
  • 主要企业市场排名/定位分析（2025 年）

第10章 企业简介(产业概要，财务概要，产品系列，策略性展开，SWOT分析)

  • IQVIA Holdings Inc.
  • Optum Inc.(UnitedHealth Group)
  • Oracle Health(formerly Cerner Corporation)
  • Merative(formerly IBM Watson Health)
  • Komodo Health Inc.
  • Inovalon Holdings Inc.
  • Datavant Inc.
  • Definitive Healthcare Corp.
  • Veeva Systems Inc.
  • Flatiron Health Inc.(Roche Group)
  • Health Catalyst Inc.
  • Innovaccer Inc.

第11章 附录

简介目录
Product Code: MRHC - 1041791

Healthcare Data Monetization Market by Data Type (Clinical Data, Claims & Financial Data, Pharmaceutical & R&D Data, Patient-Generated Data, Operational & Administrative Data), Monetization Model (Internal Monetization, External Monetization), Application, and End User - Global Forecast to 2036

According to the research report titled, 'Healthcare Data Monetization Market by Data Type (Clinical Data, Claims & Financial Data, Pharmaceutical & R&D Data, Patient-Generated Data, Operational & Administrative Data), Monetization Model (Internal Monetization, External Monetization), Application, and End User - Global Forecast to 2036,' the global healthcare data monetization market is expected to reach approximately USD 28.7 billion by 2036 from USD 569.7 million in 2026, at a CAGR of 17.6% during the forecast period (2026-2036). The report provides an in-depth analysis of the global healthcare data monetization market across five major regions, emphasizing the current market trends, market sizes, recent developments, and forecasts till 2036.

Following extensive secondary and primary research and an in-depth analysis of the market scenario, the report conducts the impact analysis of the key industry drivers, restraints, opportunities, and challenges. The major factors driving the growth of the healthcare data monetization market include the intensifying global focus on data-driven care delivery and the rapid expansion of artificial intelligence adoption. Additionally, the integration of privacy-enhancing technologies, increasing demand for high-quality health datasets, and expansion of federated data networks are expected to create significant growth opportunities for players operating in the healthcare data monetization market.

Market Segmentation

The healthcare data monetization market is segmented by data type (clinical data, claims & financial data, pharmaceutical & R&D data, patient-generated data, operational & administrative data), monetization model (internal monetization, external monetization), application, and end user. The study also evaluates industry competitors and analyzes the market at the country level.

Based on Data Type

By data type, the clinical data segment holds the largest market share in 2026, primarily attributed to the breadth and depth of structured and unstructured clinical records generated across hospitals and ambulatory care settings globally. Clinical data represents the most commercially valuable health data asset. However, the pharmaceutical & R&D data segment is expected to grow at the fastest CAGR during the forecast period, driven by the increasing demand for real-world clinical datasets to accelerate candidate identification and support regulatory submissions. Claims & financial data, patient-generated data, and operational & administrative data represent specialized segments with rapid growth potential.

Based on Monetization Model

By monetization model, the external monetization segment holds the largest market share in 2026, owing to the high commercial demand for licensed health datasets and data-as-a-service offerings from pharmaceutical, biotechnology, and research organizations. External monetization represents the primary revenue driver for healthcare data companies. The internal monetization segment is expected to witness significant growth during the forecast period, driven by healthcare organizations seeking to unlock strategic value from their proprietary data assets and improve operational efficiency.

Based on Application

By application, the drug discovery and development segment holds the largest share of the overall market in 2026, as pharmaceutical companies increasingly rely on real-world clinical datasets to accelerate candidate identification and support regulatory submissions. Drug discovery represents the most established application for health data monetization. Real-world evidence generation, precision medicine, and population health management represent emerging applications with significant growth potential.

Based on End User

By end user, the pharmaceutical and biotechnology companies segment holds the largest share of the overall market in 2026, reflecting their sustained demand for high-quality health datasets to support drug development and clinical research. Pharmaceutical and biotechnology companies represent the primary market driver. Healthcare providers, payers, research institutions, and other end-user segments represent emerging markets with rapid growth potential.

Geographic Analysis

An in-depth geographic analysis of the industry provides detailed qualitative and quantitative insights into the five major regions (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) and the coverage of major countries in each region. In 2026, North America dominates the global healthcare data monetization market with the largest market share, primarily attributed to a mature health information technology infrastructure and high electronic health record adoption rates in the United States and Canada. Asia-Pacific is expected to witness the fastest growth during the forecast period, supported by rapid digitization of healthcare systems and government-backed national health data initiatives in China, India, Japan, and Southeast Asia. Europe, Latin America, and the Middle East & Africa represent emerging markets with growing emphasis on data-driven healthcare and real-world evidence programs.

Key Players

The key players operating in the global healthcare data monetization market are IQVIA Holdings Inc., Optum Inc., Inovalon Holdings Inc., Komodo Health Inc., Datavant Inc., Flatiron Health (Roche), Tempus AI, Veradigm LLC, and various other regional and emerging health data analytics and data monetization service providers, among others.

Key Questions Answered in the Report-

  • What is the current revenue generated by the healthcare data monetization market globally?
  • At what rate is the global healthcare data monetization market demand projected to grow for the next 7-10 years?
  • What are the historical market sizes and growth rates of the global healthcare data monetization market?
  • What are the major factors impacting the growth of this market at the regional and country levels? What are the major opportunities for existing players and new entrants in the market?
  • Which segments in terms of data type, monetization model, application, and end user are expected to create major traction for the service providers in this market?
  • What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the companies operating in the global healthcare data monetization market?
  • Who are the major players in the global healthcare data monetization market? What are their specific product offerings in this market?
  • What are the recent strategic developments in the global healthcare data monetization market? What are the impacts of these strategic developments on the market?

Scope of the Report:

Healthcare Data Monetization Market Assessment -- by Data Type

  • Clinical Data
  • Claims & Financial Data
  • Pharmaceutical & R&D Data
  • Patient-Generated Data
  • Operational & Administrative Data

Healthcare Data Monetization Market Assessment -- by Monetization Model

  • Internal Monetization
  • External Monetization

Healthcare Data Monetization Market Assessment -- by Application

  • Drug Discovery and Development
  • Real-World Evidence Generation
  • Precision Medicine
  • Population Health Management
  • Others

Healthcare Data Monetization Market Assessment -- by End User

  • Pharmaceutical and Biotechnology Companies
  • Healthcare Providers
  • Payers
  • Research Institutions
  • Others

Healthcare Data Monetization Market Assessment -- by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Scope
  • 1.3. Research Methodology
  • 1.4. Assumptions & Limitations

2. Executive Summary

3. Market Overview

  • 3.1. Introduction
  • 3.2. Market Dynamics
    • 3.2.1. Drivers
    • 3.2.2. Restraints
    • 3.2.3. Opportunities
    • 3.2.4. Challenges
  • 3.3. Impact of AI and Cloud Technologies on Healthcare Data Monetization
  • 3.4. Regulatory Landscape & Data Privacy Frameworks
  • 3.5. Porter's Five Forces Analysis

4. Global Healthcare Data Monetization Market, by Data Type

  • 4.1. Introduction
  • 4.2. Clinical Data
    • 4.2.1. Electronic Health Records (EHR) Data
    • 4.2.2. Medical Imaging Data
    • 4.2.3. Laboratory & Diagnostic Data
  • 4.3. Claims & Financial Data
    • 4.3.1. Insurance Claims Data
    • 4.3.2. Billing & Reimbursement Data
  • 4.4. Pharmaceutical & R&D Data
    • 4.4.1. Clinical Trial Data
    • 4.4.2. Drug Utilization & Outcomes Data
  • 4.5. Patient-Generated Data
    • 4.5.1. Wearable & Remote Monitoring Data
    • 4.5.2. Consumer Health Application Data
  • 4.6. Operational & Administrative Data
    • 4.6.1. Workforce & Scheduling Data
    • 4.6.2. Supply Chain & Procurement Data

5. Global Healthcare Data Monetization Market, by Monetization Model

  • 5.1. Introduction
  • 5.2. Internal Monetization
    • 5.2.1. Operational Efficiency & Cost Reduction
    • 5.2.2. Clinical Performance Improvement
  • 5.3. External Monetization
    • 5.3.1. Data Licensing & Data-as-a-Service (DaaS)
    • 5.3.2. Research & Analytics Partnerships
    • 5.3.3. Real-World Data Marketplaces

6. Global Healthcare Data Monetization Market, by Application

  • 6.1. Introduction
  • 6.2. Drug Discovery & Development
  • 6.3. Clinical Trials Management
  • 6.4. Population Health Management
  • 6.5. Revenue Cycle Management
  • 6.6. Precision Medicine
  • 6.7. Healthcare Operations Optimization

7. Global Healthcare Data Monetization Market, by End User

  • 7.1. Introduction
  • 7.2. Pharmaceutical & Biotechnology Companies
    • 7.2.1. Large Pharmaceutical Companies
    • 7.2.2. Specialty Pharma & Biotech Firms
  • 7.3. Healthcare Providers
    • 7.3.1. Hospital Systems & Integrated Delivery Networks
    • 7.3.2. Ambulatory & Specialty Care Providers
  • 7.4. Payers
    • 7.4.1. Commercial Health Insurers
    • 7.4.2. Government & Public Payers
  • 7.5. Medical Device Manufacturers
    • 7.5.1. Diagnostic Device Companies
    • 7.5.2. Digital Health & Wearable Device Companies
  • 7.6. Healthcare IT Companies
    • 7.6.1. EHR & Health Information System Vendors
    • 7.6.2. Health Analytics Platform Providers
  • 7.7. Government & Research Institutions
    • 7.7.1. Academic Medical Centers
    • 7.7.2. Public Health Agencies & National Research Bodies

8. Global Healthcare Data Monetization Market, by Region

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. U.S.
    • 8.2.2. Canada
  • 8.3. Europe
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Netherlands
    • 8.3.7. Rest of Europe
  • 8.4. Asia-Pacific
    • 8.4.1. China
    • 8.4.2. India
    • 8.4.3. Japan
    • 8.4.4. South Korea
    • 8.4.5. Southeast Asia
    • 8.4.6. Australia
    • 8.4.7. Rest of Asia-Pacific
  • 8.5. Latin America
    • 8.5.1. Brazil
    • 8.5.2. Mexico
    • 8.5.3. Rest of Latin America
  • 8.6. Middle East & Africa
    • 8.6.1. Saudi Arabia
    • 8.6.2. UAE
    • 8.6.3. South Africa
    • 8.6.4. Rest of Middle East & Africa

9. Competitive Landscape

  • 9.1. Overview
  • 9.2. Key Growth Strategies
  • 9.3. Competitive Benchmarking
  • 9.4. Competitive Dashboard
    • 9.4.1. Industry Leaders
    • 9.4.2. Market Differentiators
    • 9.4.3. Vanguards
    • 9.4.4. Emerging Companies
  • 9.5. Market Ranking / Positioning Analysis of Key Players, 2025

10. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments, SWOT Analysis)

  • 10.1. IQVIA Holdings Inc.
  • 10.2. Optum Inc. (UnitedHealth Group)
  • 10.3. Oracle Health (formerly Cerner Corporation)
  • 10.4. Merative (formerly IBM Watson Health)
  • 10.5. Komodo Health Inc.
  • 10.6. Inovalon Holdings Inc.
  • 10.7. Datavant Inc.
  • 10.8. Definitive Healthcare Corp.
  • 10.9. Veeva Systems Inc.
  • 10.10. Flatiron Health Inc. (Roche Group)
  • 10.11. Health Catalyst Inc.
  • 10.12. Innovaccer Inc.

11. Appendix

  • 11.1. Questionnaire
  • 11.2. Related Reports